Comparative effective dose of ciprofol and propofol in suppressing cardiovascular responses to tracheal intubation: a single-center, double-blind, randomized, controlled clinical trial
Authors:
Preprint
- 13 February 2024
- preprint
- Published by Springer Nature in Research Square
Abstract
Ciprofol, a novel γ-aminobutyric acid receptor agonist, outperforms propofol with minimal cardiovascular effects, higher potency, reduced injection pain, and a broader safety margin. Despite these advantages, ciprofol's clinical research is still emerging. This study compares the median effective dose (ED50) and adverse reactions of ciprofol and propofol, in conjunction with sufentanil, for suppressing cardiovascular responses during tracheal intubation.A total of fifty-three adult patients who required general anesthesia for tracheal intubation were enrolled in this study. The patients were randomly assigned to either the ciprofol group (group C) or the propofol group (group P) using a random number table. Tracheal intubation was performed using a standardized laryngoscope and endotracheal tube. The Dixon's up-and-down method was employed to determine the ED50 and 95% effective dose (ED95) of ciprofol and propofol in inhibiting cardiovascular responses during tracheal intubation. Based on the pilot study, the initial dose of ciprofol was set at 0.35 mg/kg (with a dose increment of 0.01 mg/kg) and propofol was set at 2.0 mg/kg (with a dose increment of 0.1 mg/kg). Dose-response curves were generated using probit analysis to establish the ED50 and ED95 required to inhibit cardiovascular responses during tracheal intubation. Adverse events following drug administration were closely monitored.A total of 54 participants were included in the study, with 24 in group C (one participant excluded due to repeated intubation) and 30 in group P. Probit analysis revealed that the ED50 and ED95 of ciprofol for inhibiting cardiovascular responses to tracheal intubation were 0.326 mg/kg (95% CI 0.304-0.337 mg/kg) and 0.349 mg/kg (95% CI 0.337-0.470 mg/kg), and for propofol, 1.541 mg/kg (95% CI 1.481-1.599 mg/kg) and 1.656 mg/kg (95% CI 1.599-1.943 mg/kg). Notably, group C demonstrated more stable hemodynamics during induction and showed a significantly lower incidence of injection pain compared to group P. Ciprofol demonstrated more stable hemodynamics and a lower incidence of adverse events during induction. Ciprofol may potentially be used as a substitute for propofol in a wider range of scenarios. Clinical Trial Registration: hppts://ClinicalTrials.gov; Identifier: NCT06095570(23/10/2023).Keywords
All Related Versions
- Version 1, 2024-02-13, Research Square
- Published version: Scientific Reports, 15 (1), 1.
This publication has 30 references indexed in Scilit:
- Safety, Pharmacokinetics, and Pharmacodynamics of a Single Bolus of the γ-aminobutyric Acid (GABA) Receptor Potentiator HSK3486 in Healthy Chinese Elderly and Non-elderlyFrontiers in Pharmacology, 2021
- Management of Ambulatory Anesthesia in Older AdultsDrugs & Aging, 2020
- Shared structural mechanisms of general anaesthetics and benzodiazepinesNature, 2020
- Mass balance, pharmacokinetics and pharmacodynamics of intravenous HSK3486, a novel anaesthetic, administered to healthy subjectsBritish Journal of Clinical Pharmacology, 2020
- Propofol infusion syndrome: a structured literature review and analysis of published case reportsBritish Journal of Anaesthesia, 2019
- Gender Affects the Median Effective Dose and 95% Effective Dose of Oxycodone for Blunting the Hemodynamic Response to Tracheal Intubation in Narcotic-Naïve Adult PatientsChinese Medical Journal, 2018
- Guidelines for the management of tracheal intubation in critically ill adultsBritish Journal of Anaesthesia, 2018
- Design, Synthesis, and Evaluation of Novel 2,6-Disubstituted Phenol Derivatives as General AnestheticsJournal of Medicinal Chemistry, 2017
- The efficacy of labetalol vs dexmedetomidine for attenuation of hemodynamic stress response to laryngoscopy and endotracheal intubationJournal of Clinical Anesthesia, 2016
- Dose-dependent hemodynamic effects of propofol induction following brotizolam premedication in hypertensive patients taking angiotensin-converting enzyme inhibitorsJournal of Clinical Anesthesia, 2010